Staff >> Faculty >> Dr. Biju George

Dr. Biju George MBBS, MD, DM

Professor, Haematology

Areas of interest include aplastic anemia, myelodysplastic syndromes, stem cell transplantation, graft versus host disease, ITP, infections and immunotherapy

Areas of interest include aplastic anemia, myelodysplastic syndromes, stem cell transplantation, graft versus host disease, ITP, infections and immunotherapy

Education

Duration	Description of Qualification	College/University
July 1986 to December 1990	MBBS	Christian Medical College, Vellore Madras University Chennai
March1995 to March 1998	MD (General Medicine)	Christian Medical College, Vellore Dr MGR Medical University, Chennai
February 2000 to January 2002	DM (Clinical Haematology)	Christian Medical College, Vellore Dr MGR Medical University, Chennai

Licenses and Certifications

• MD in Internal Medicine 1998
• DM in Clinical Haematology 2002
• Registered with NSW Medical Board, Australia 2007

Professional Affiliations

• Member Indian Society of Haematology and Transfusion Medicine
• Member American Society of Bone Marrow Transplantation (ASBMT)
• Member American Society of Hematology
• Member Asia Pacific Bone Marrow Transplantation (APBMT)

Professional Experience

• Resident Medical Officer at Methodist Public Health Centre, Mursan, UP between 1992 – 1994
• Non-Post Graduate (PG) registrar in department of Haematology, CMC Vellore between 1994 – 1995
• Residency Postgraduate Training in Internal Medicine, CMC Vellore: 1995 – 1998
• Lecturer of Medicine in Haematology: 1998 – 2000
• Subspecialty training in Clinical Haematology, CMC Vellore: 2000–2002
• Lecturer/Assistant Professor/Associate Professor in Haematology, CMC Vellore between 2002 – 2007
• Registrar, Westmead Hospital, Sydney, Australia: March 2007 till January 2008
• Post graduate Clinical Fellow, Westmead Hospital, Sydney, Australia between February 2008 till March 2010
• Professor, Department of Haematology, CMC Vellore: March 2010 till present

Reviewer of papers submitted to the following journals

• Pediatric Transplantation
• Bone Marrow Transplantation
• Annals of Transplantation
• Journal of Hematology and Oncology
• British Journal of Haematology
• National Medical Journal of India
• Biology of Blood and Marrow Transplantation
• Acta Haematologica

Email: biju@cmcvellore.ac.in
Phone:+91 416 2282169/101

1. George B, Thomas K, Danda D. Vasculitis – a current approach. Indian Journal of Rheumatology April 1998. 

2. Singh S, Cherian RS, George B, Nair S, Srivastava A. Unusual extra-axial central nervous system involvement of non-Hodgkin's lymphoma: magnetic resonance imaging. Australas Radiol. 2000 Feb; 44(1): 112-4.

3. George B, Danda D, Chandy M, Srivastava A, Mathews V.  Polymyositis – an unusual manifestation of chronic graft versus host disease. Rheumatol Int 2001; 20(4): 169 -70. 

4. Chandy M, Srivastava A, Dennison D, Mathews V, George B.  Allogeneic bone marrow transplantation in the developing world: experience from a center in India. Bone Marrow Transplantation 2001; 27: 785 - 790.

5. Mathews V, George B, Srivastava A, Chandy M. Central nervous system relapse in a patient with acute promyelocytic leukemia treated with arsenic. Br J Haematol 2001; 113 (1): 257-58.

6. George B, Mathews V, Srivastava A, Chandy M. Tuberculosis among allogeneic marrow transplant recipients in India. Bone Marrow Transplantation 2001, 27; 973-975.

7. Subhash HS, George P, Sowmya G, George B, Ashwin I, Cherian AM Progressive dilated cardiomyopathy in a patient with hypereosinophilic syndrome despite prednisone induced hematological remission. J Assoc Physicians India 2001 Sep; 49: 944-5.

8. George Joseph, Ashish kumar, TU Zachrias, Biju George. Severe intravascular hemolysis after transcatheter closure of a large patent ductus arteriosus using the Amplatzer duct occluder. Catheterization & Cardiovascular intervention 2002; 55: 245-9.

9. Naina HVK, Nair SC, Daniel D, George B, Chandy M. Asymptomatic constitutional macrothrombocytopenia among West Bengal blood donors. Am J Med 2002 Jun 15; 112(9): 742 - 43.

10. Vikram Mathews, Poonkuzhali Balasubramanian, RV Shaji, Biju George, Mammen Chandy, Alok Srivastava. Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: A single center experience. American Journal of Haematology 2002; 70 (4): 292-99.

11. Subhash HS, George B, Devi A, John G, Chandy M, Srivastava A. Patients with
hematological disorders requiring admission to Medical Intensive Care Unit: Characteristics
survival and prognostic factors. IJCCM 2003; 7:2: 88 – 93.

12. George B, Mathews V, Srivastava A, Chandy M. Infections among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2004 Feb; 33(3): 311-15.

13. Srivastava A, Poonkuzhali B, Shaji RV, George B, Mathews V, Chandy M, Krishnamoorthy R. Glutathione S - Transferase M1 Polymorphism - A risk factor for hepatic Venoocclusive Disease in bone marrow transplantation. Blood 2004 Sep 1; 104(5): 1574 - 77.

14. Jayandhran G, Shaji RV, George B, Chandy M, Srivastava A. Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India. Haemophilia 2004 Sep; 10(5): 553- 9.

15. George B, Mathews V, Poonkuzhali B, Shaji RV, Srivastava A, Chandy M. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide – a single center experience. Leukemia 2004 Oct; 18(10): 1587-90.

16. Biju George, Vikram Mathews, Poonkuzhali Balasubramanian, RV Shaji, Alok Srivastava, Mammen Chandy. Molecular remission with As2O3 in patients with newly diagnosed Acute promyelocytic leukemia (APML). Haematologica 2004 Oct; 89(10): 1266-67.

17. George B, Poonkuzhali B, Srivastava VM, Chandy M, Srivastava A. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RAR alpha acute promyelocytic leukemia (APML). Ann Hematol 2005 June; 6: 406-8.

18. George B, Mathews V, Shaji RV, Srivastava V, Srivastava A, Chandy M. Fludarabine based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant 2005 Feb; 35(4): 341-3.

19. Poonkuzhali B, Shaji RV, Salamun DE, George B, Srivastava A, Chandy M. Cytochrome P4501A1 and Glutathione S Transferase Gene Polymorphisms in patients with aplastic anemia in India. Acta Haematol 2005; 114(3): 127 - 132.

20. M Unni, MV Jesudason, S Rao, B George. Mycobacterium Fortuitum bacteremia in an immuncompromised patient. Ind J Med Microbiol Apr 2005; 23(2): 137 - 8.

21. Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, George B, Chandy M, Srivastava A. Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T→G factor X gene mutations is responsible for congenital factor X deficiency in patients of Nepali and Indian origin. J Thromb Haemost  2005 Jul; 3(7): 1482 - 87.

22. Sharat Damodar, Biju George, Joy Mammen, Vikram Mathews, Alok Srivastava, Mammen Chandy. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of PRCA in major ABO mismatched transplants. Bone Marrow Transplant 2005 Aug; 36(3): 233 - 35.

23. Sivakumar S, Mary Mathews, Biju George. Cunninghamella pneumonia in a post bone marrow transplant patient. First case report from India. Mycoses 2005 Sep; 48(5): 360-62. 

24. Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults - a report on 90 patients. Eur J Haematol 2005 Oct; 75(4): 328 - 331.

25. Mammen Chandy, Poonkuzhali Balasubramanian, Shaji Ramachandran, Vikram Mathews, Biju George, David Dennison, Rajagopal Krishnamoorthy and Alok Srivastava. Randomized trial of two different conditioning regimes for bone marrow transplantation in thalassemia - The role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant 2005 Nov; 36(10): 839 – 845. 

26. Mathews V, Viswabandya A, Baidya S, George B, Nair S, Chandy M, Srivastava A. Surgery for hemophilia in developing countries. Semin Thromb Hemos 2005 Dec; 31(5): 538- 43.

27. Biju George, Vikram Mathews, Auro Viswabandya, Alok Srivastava, Mammen Chandy. Infections in children undergoing allogeneic bone marrow transplantation in India. Paed Transplantation Feb 2006: 10: 48–54.

28. Mathews V, George B, Lakshmi KM, Viswabandya A, Bajel A, Balasubramaniam P, Shaji RV, Srivastava VM, Srivastava A, Chandy M. Single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 2006 April 1; 107(7): 2627-32.

29. Giridhara R. Jayandharan, Auro Viswabandya, Shoma Baidya, Sukesh C. Nair, Biju George, Vikram Mathews, Mammen Chandy, Alok Srivastava Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach. Thromb Haemost 2006; 95: 551–6.

30. Sellathamby S, Balasubramaniam P, Sivalingam S, Shaji RV, Mathews V, George B, Viswabandya A, Srivastava A, Chandy M. Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation. Bone Marrow Transplant 2006 Apr; 37(8): 751-5.

31. Mathews V, Desire S, George B, Lakshmi KM, Rao JG, Viswabandya A, Bajel A, Srivastava VM, Srivastava A, Chandy M. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. Leukemia 2006 May; 20(5): 881-3.

32. Deotare UR, Vishwabandya A, Mathews V, George B, Srivastava A, Chandy M. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation. Bone Marrow Transplant 2006 Jun; 37(12): 1149 - 50.

33. Subramaniam K, George B, Mathews V, Viswabandya A, Srivastava A, Chandy M. Salvage with a mini-allograft after primary engraftment following autologous transplant for multiple myeloma. Bone Marrow Transplant 2007 Feb; 39(4): 239–40.

34. Balamugesh T, Christopher DJ, George B, Rajesh T. Strongyloidosis hyperinfection in a neutropenic host diagnosed by bronchoalveolar lavage. Indian J Chest Dis Allied Sci 2007 Jan-Mar; 49(1): 37-9.

35. George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant 2007 July; 40(1): 13 -18.

36. Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Adult ALL: Study of treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia 2007 Oct; 21(10): 2230-3.

37. Mathews V, Thomas M, Srivastava VM, George B, Srivastava A, Chandy M Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen. Haematologica 2007 Jul; 92(7): 994-5.

38. Lee VN, Srivastava A, Nithyananth M, Kumar P, Cherian VM, Viswabandya A, Mathews V, George B, Venkatesh K, Nair SC, Chandy M, Sundararaj GD. Fracture neck of femur in haemophilia A - experience from a cohort of 11 patients from a tertiary centre in India. Haemophilia 2007 Jul; 13(4): 391-4.

39. Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D, Chandy M, Srivastava A. A new stratification strategy that identifies a subset of Class III patients with an adverse prognosis among children with beta Thalassemia Major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007 Aug; 13(8): 889-94.

40. Thankachen R, George B, Shukla V, Korula RJ. Aortic and mitral valve replacement in a patient with hemophilia B. Asian Cardiovasc Thorac Ann. 2007 Dec; 15(6): 526-7.

41. George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine based reduced intensity conditioning (RIC) regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia. Paediatric Transplant Feb 2008; 12(1): 14-9.

42. Reena Rajasekar, Vikram Mathews, Kavitha M Lakshmi, Shanmugaapriya Sellathamby, Biju George, Auro Viswabandya, Dolly Daniel, Mammen Chandy, Alok Srivastava. Plasmacytoid dendritic cell count on Day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD. Biology of Blood and Marrow Transplantation 2008; 14: 344-350.

43. Edison ES, Shaji RV, Devi SG, Moses A, Viswabandhya A, Mathews V, George B, Srivastava A, Chandy M. Analysis of beta globin mutations in the Indian population: presence of rare and novel mutations and region-wise heterogeneity. Clin Genet. 2008 Apr; 73(4): 331-7.

44. A. Viswabandya, V. Mathews, B. George, S.C. Nair, S. Baidya, J.J. Mammen, M. Chandy, A. Srivastava. Successful surgical hemostasis in patients with von Willebrands disease with Koate DVI. Haemophilia 2008 July 14(4): 763-7.

45. George B, Kerridge I, Gottlieb D, Huang G, Hertzberg M, Svennilson J, Bradstock K. A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis. Bone Marrow Transplant 2008 October; 42(8): 567-8.

46. Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH. Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood 2008 Oct 15; 112(8): 3500-7.

47. Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer 2008 Nov 51(5): 621-5.

48. Aaron S, Alexander M, Thomas M, George B, Mammen J. Cerebral venous thrombosis due to homozygous factor V Leiden mutation. Neurol India 2009 Jan-Feb; 57(1): 91

49. George B, Mathews V, Viswabandya A, Srivastava A, Chandy M. Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections. Clin Transplant 2009 Mar; 23 (2): 228-32.

50. Vikram Mathews, Biju George, Kavitha M Lakshmi, Auro Viswabandya, Joseph M John, Usha Sitaram, Dolly Daniel, Mammen Chandy, Alok Srivastava. Impact of Pre-transplant Splenectomy on Patients with β Thalassemia Major Undergoing a Matched Related Allogeneic Stem Cell Transplantation. Pediatric Transplantation 2009 March; 13(2): 171-6. 

51. Rajasekar R, Mathews V, Lakshmi KM, George B, Viswabandya A, Chandy M, Srivastava A. Cellular Immune Reconstitution and Its Impact on Clinical Outcome in Children with β Thalassemia Major Undergoing a Matched Related Myeloablative Allogeneic Bone Marrow Transplant. BBMT 2009 May; 15(5): 597 – 609.

52. Jayandharan GR, Nair SC, Poonnoose PM, Thomas R, John J, Keshav SK, Cherian RS, Devadarishini M, Lakshmi KM, Shaji RV, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Polymorphism in factor VII gene modifies phenotype of severe haemophilia. Haemophilia 2009 Nov; 15(6): 1228-36.

53. Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P,

Viswabandya A, Srivastava A, Chandy M, Mathews V. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biol Blood Marrow Transplant 2009 Nov; 15(11):1479 - 84.

54. Bradstock K, Hertzberg M, Kerridge I, Svennilson J, George B, McGurgan M, Huang G, Antonenas V, Gottlieb D. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced hematological malignancies: a retrospective comparison of outcomes. Intern Med J. 2009 Nov, 39(11); 744-51. 

55. Markose P, Chendamarai E, Balasubramanian P, Velayudhan SR, Srivastava VM, Mathews V, George B, Viswabandya A, Srivastava A, Chandy M. Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions. Leuk Lymphoma 2009 Dec; 50(12): 2092-5.

56. George B, Mathews V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M. Allogeneic hematopoietic stem cell transplantation using matched sibling donors is superior to immunosuppressive therapy in Indian children with aplastic anemia - a single centre analysis of 100 patients. Pediatr Hematol Oncol 2010 March; 27(2): 122-31.

57. Brian McClune, Daniel Weisdorf, Tanya Pedersen, Gisela Tunes de Silva, Martin Tallman, Jorge Sierra,  John DiPersio, Armand Keating, Robert Gale, Biju George, Vikas Gupta, Theresa Hahn, Luis Isola, Madan Jagasia, Hillard Lazarus, David Marks, Richard Maziarz, Edmund Waller, Chris Bredeson, Sergio Giralt. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission and myelodysplastic syndrome. J Clin Oncol 2010 Apr 10; 28(11): 1878 – 87.

58. George B, Kerridge I, Gilroy N, Huang G, Hertzberg M, Gottlieb D, Bradstock K. Fludarabine based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. Bone Marrow Transplant 2010 May; 45(5): 849-55.  

59. Rajasekar R, Lakshmi KM, George B, Viswabandya A, Thirugnanam R, Abraham A, Chandy M, Srivastava A, Mathews V. Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant. Biol Blood Marrow Transplant 2010 Jun; 16(6): 854-60.

60. Viswabandya A, Baidya S, Nair SC, Lakshmi KM, Mathews V, George B, Chandy M, Srivastava A. Clinical manifestations of combined factor V and VIII deficiency: A series of 37 cases from a single center in India. Am J Hematol 2010 Jul; 85(7): 538-539.

61. Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, Harper JM, Thursky K, Worth LJ, Dwyer DE, Morrissey CO, Johnson PD, Buising KL, Harrison SJ, Seymour JF, Ferguson PE, Wang B, Denholm JT, Cheng AC, Slavin M. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010 Jul; 16(7):1068-75.

62. David I Marks, Tao Wang, Waleska S Perez, Joseph H Antin, Edward A Copelan, Robert Peter Gale, Biju George, Vikas Gupta, Joerg Halter, Hanna Jean Khoury, Thomas R Klumpp, Hillard M Lazarus, Victor A Lewis, Philip L McCarthy, David A Rizzieri, Mitchell Sabloff, Jeff Szer, Martin S Tallman, Daniel J Weisdorf. The outcome of full intensity versus reduced intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome negative acute lymphoblastic leukemia in first and second complete remission. Blood 2010 July 22; 116(3): 366-74.

63. George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K. Pre-transplant cytomegalovirus serostatus continues to remain the most important determinant of cytomegalovirus (CMV) reactivation following allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transplant Infect Diseases 2010 Aug 1; 12(4): 322-9.

64. Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya A, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M. Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data. J Clin Oncol. 2010 Aug 20; 28(24): 3866-71.

65. Gupta M, Ashok Kumar J, Sitaram U, Neeraj S, Nancy A, Balasubramanian P, Abraham A, Mathews V, Viswabandya A, George B, Chandy M, Srivastava A, Srivastava VM. The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases. Cancer Genet Cytogenet. 2010 Dec; 203(2): 297-302.

66. Desire S, Balasubramanian P, Bajel A, George B, Viswabandya A, Mathews V, Srivastava A, Chandy M. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine. Med Oncol 2010 Dec; 27(4): 1046 – 9. .

67. Biju George, Patricia Ferguson, Ian Kerridge, Nicole Gilroy, David Gottlieb, Mark Hertzberg. The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients. BBMT 2011 Jan; 17(1): 147-53.

68. Chapla A, Jayandharan GR, Sumitha E, Sankari Devi G, Shenbagapriya P, Nair SC, Viswabandya A, George B, Mathews V, Srivastava A. Molecular basis of hereditary factor V deficiency in India: Identification of four novel mutations and their genotype-phenotype correlation. Thromb Haemost. 2011 Jun 6; 105(6):1120-3.

69.  Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M. Comparison of Outcomes after Transplantation of G-CSF Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia Biology of Blood and Marrow Transplantation. BBMT 2011 July; 17(7); 1018-24.

70. Sumitha E, Jayandharan GR, David S, Jacob RR, Sankari Devi G, Bargavi B, Shenbagapriya S, Nair SC, Abraham A, George B, Viswabandya A, Mathews V, Chandy M, Srivastava A. Molecular basis of Bernard Soulier Syndrome in 27 patients from India. J Thromb Haemost. 2011 Aug; 9(8): 1590-8.

71. Parihar M, Ashok Kumar J, Sitaram U, Balasubramanian P, Abraham A, Viswabandya A, George B, Mathews V, Srivastava A. Cytogenetic analysis of acute myeloid leukaemia with t(8;21) from a tertiary care centre in India with correlation between clinicopathological characteristics and molecular analysis. Leuk Lymphoma. 2012 Jan; 53(1): 103-9.

72. George L, George B, Gottlieb DJ, Hertzberg M, Fernandez-Penas P. Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD. Bone Marrow Transplant 2012 May; 47(5): 737-8. .

73. Patkar N, Nair S, Alex AA, Parihar M, Manipadam MT, Arora N, Ahmed R, Abraham A, George B, Viswabandya A, Srivastava V, Srivastava A, Mathews V. Clinicopathological Features of Hepatosplenic T Cell Lymphoma: A Single Centre Experience from India. Leuk Lymphoma 2012 Apr; 53(4): 609-15.

74. Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. Bone Marrow Transplant 2011 Oct 10: epub ahead of print

75. George B, Benson W, Hertzberg MS. A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma. Bone Marrow Transplant. 2011 Oct 17. [Epub ahead of print].

76. Mathews V, Chendamarai E, George B, Viswabandya A, Srivastava A. Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide. Mediterr J Hematol Infect Dis. 2011; 3(1):e2011056. Epub 2011 Nov 28.

77. Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, Chandy M, Srivastava A. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia. 2012 May; 18(3): 195-200.

78. Balasubramanian P, Desire S, Panetta JC, Lakshmi KM, Mathews V, George B, Viswabandya A, Chandy M, Krishnamoorthy R, Srivastava A. Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT. Bone Marrow Transplant. 2012 Jan 9. doi: 10.1038/bmt.2011.254. [Epub ahead of print].

79. Edison ES, Venkatesan RS, Govindanattar SD, George B, Shaji RV. A Novel 26 bp Deletion [HBB: c.20_45del26bp] in Exon 1 of the β-Globin Gene Causing β-Thalassemia Major. Hemoglobin. 2012; 36(1): 98-102.

80. Balasubramanian P, Chendamarai E, Markose P, Fletcher L, Branford S, George B, Mathews V, Chandy M, Srivastava A. International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India. Acta Haematol. 2012 Jan 12; 127(3): 135-142.

81. Sellathamby S, Lakshmi KM, Busson M, Viswabandya A, George B, Mathews V, Chandy M, Charron D, Krishnamoorthy R, Tamouza R, Srivastava A. Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation (HSCT). Biol Blood Marrow Transplant. 2012 Jan 14. [Epub ahead of print].

82. George B, Kerridge IH, Gilroy N, Huang G, Hertzberg MS, Bradstock KF, Gottlieb DJ. A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group. Transpl Infect Dis. 2012 April; 14(2): 141-8.

83. Abraham A, Varatharajan S, Abbas S, Zhang W, Shaji RV, Ahmed R, Abraham A, George B, Srivastava A, Chandy M, Mathews V, Balasubramanian P. Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia. Pharmacogenomics. 2012 Feb; 13(3): 269-82.

84. Chendamarai E, Balasubramanian P, George B, Viswabandya A, Abraham A, Ahmed R,

Alex AA, Ganesan S, Lakshmi KM, Sitaram U, Nair SC, Chandy M, Janet NB, Srivastava VM, Srivastava A, Mathews V. Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy. Blood. 2012 Apr 12; 119(15): 3413-9.

85. Battiwalla M, Wang T, Carreras J, Joachim Deeg H, Ayas M, Bajwa RP, George B, Gupta V, Pasquini R, Schrezenmeier H, Passweg JR, Schultz KR, Eapen M. HLA-matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft vs. Host Disease and Overall Survival. Biol Blood Marrow Transplant. 2012 Feb 28. [Epub ahead of print] PubMed PMID: 22387349.

86. Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani B, Aljurf MD, Cairo MS, Drobyski WR, George B, Hahn T, Khera N, Litzow MR, Loren AW, Saber W, Arora M, Urbano-Ispizua A, Cutler C, Flowers ME, Spellman SR. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2012 Mar 10. [Epub ahead of print] PubMed PMID: 22414493.

87. Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W. Allogeneic Hematopoietic Cell Transplantation for Advanced Polycythemia Vera and Essential Thrombocythemia. Biol Blood Marrow Transplant. 2012 Mar 24. [Epub ahead of print] PubMed PMID: 22449610.

88. Patkar N, Alex AA, B B, Ahmed R, Abraham A, George B, Vishwabandya A, Srivastava A, Mathews V. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country. Cytometry B Clin Cytom. 2012 Jul; 82(4): 252-8. .

89. Varatharajan S, Abraham A, Zhang W, Shaji RV, Ahmed R, Abraham A, George B, Srivastava A, Chandy M, Mathews V, Balasubramanian P. Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia. Eur J Clin Pharmacol. 2012 May 5. [Epub ahead of print] PubMed PMID: 22562609.

90. Bilmon IA, Kwan J, Gottlieb D, Kerridge I, McGurgan M, Huang G, George B, Hertzberg M, Bradstock KF. Haploidentical bone marrow transplants for hematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre. Intern Med J. 2012 May 30. doi:
10.1111/j.1445-5994.2012.02843.x. [Epub ahead of print] PubMed PMID: 22646924.

91. David S, Jayandharan GR, Abraham A, Rr J, Devi GS, Patkar N, Shaji RV, Nair SC, Viswabandya A, Ahmed R, George B, Mathews V, Chandy M, Srivastava A. Molecular basis of Wiskott-Aldrich syndrome in patients from India. Eur JHaematol. 2012 Jun 9. doi: 10.1111/j.1600-0609.2012.01818.x. [Epub ahead of print] PubMed PMID: 22679904.